Latest progress of percutaneous thernel ablation treatment for secondary hyperparathyroidism (a literature review)

With the development of dialysis treatment, the survival time of patients with CKD has been significantly prolonged. There have been a series of complications that seriously affect the patients' quality of life and even life-threatening. Among them, SHPT is one of the most common and serious complications in patients with chronic renal failure. As the disease progresses, medical treatment effect was gradually weakend, requiring surgery or interventional intervention. There are two types of SHPT interventional therapies. One is chemical ablation, which is percutaneous ultrasound-guided ethanol injecttion, and the other is thermal ablation, including ultrasound-guided percutaneous radiofrequency and microwave thermal ablation. The ethanol injection has gradually been eliminated due to the high recurrence rate after injection. Thermal ablation is a newly developed ultrasound-guided intervention technique. Due to it's minimally invasive, significantly reduced parathyroid hormone, therefore it was gradually accepted by the medical community Thermal ablation treatment provides a new direction for the treatment of SHPT in CKD patients, especially refractory SHPT. We believe in the near future, with the continuous deepening of clinical applications and research, thermal ablation treatment will continue to be standardized and improved. It is expected to become an important way to treat SHPT. The purpose of this review is to summarize the latest progress of thermal ablation treatment of SHPT, which aims to increase our understanding of the thermal ablation treatment and its application for patients with SHPT.